Addiction is a gradual process that begins with occasional use and progresses to regular consumption, eventually leading to uncontrolled substance abuse. The main problem facing the practitioners is the high rate of return among abusers with an unsuccessful attempt to stop substance consumption. Substance abuse is a worldwide phenomenon that has caused the most severe damage to human societies. It is an uncompromising model of substance abuse that can cause acute symptoms, including a set of cognitive, behavioral, and psychological symptoms (
1). Approximately 200 million people aged 15 - 64 worldwide take an illicit substance at least once a year (
2). Iran, in this regard, has a large number of addicted people to substances due to its geographical characteristics and its borders with drug-producing countries (
1). The last report of Iran’s drug control headquarter indicates the presence of 1.2 - 2 million consumers in the country. Furthermore, many individuals are either addicts or have at least someone addicted in their families (
2).
The accumbens (AC) nucleus is a part of several groups in subcortical
nuclei called the basal ganglia (basal
nuclei). It plays a vital role in the return to substance use, and its stimulation produces promising results in the treatment of substance dependence. The AC sends efferent to areas such as the frontal cortex, limbic areas, amygdala, hypothalamus, and midbrain, which greatly contribute to the processes involved in reward. Studies have shown that addiction can decrease the activity of areas such as the cingulate cortex and dorsolateral prefrontal cortex (DLPFC), which, in turn, decreases a person's control over his behavior and ultimately leads to addiction. On the other hand, the AC receives important inputs from the prefrontal cortex, which affects the activity of the AC region and the addictive behaviors of the individual. One of the target areas studied when investigating DBS and addiction is the prefrontal cortex – the medial prefrontal cortex (mPFC), in particular (
3). A behavioral study has evaluated the effect of high and low-frequency stimulation of mPFC (
4) on dependency manners.
To date, no approved drug treatment has been developed for stimulant substance abuse. However, a new class of neurosurgery interventions has become popular to treat movement disorders and mood disorders. One of these prominent therapies is deep brain stimulation (DBS) (
5). Electrical current, typically at frequencies above 100 Hz, is directed through electrodes implanted surgically in the subcortical brain nuclei (
6). Preclinical studies and case studies have reported the therapeutic effects of DBS on addiction. Recent findings about the neural pathways affected by addiction have created a new range of possibilities for the treatment of addiction by targeting the involved neural pathways and returning their activity to normal status. There is a need for new effective interventions for patients who do not benefit from conventional treatments, since addiction is a chronic brain disease that seriously affects individual and social health (
7).
In this respect, DBS research has explored various areas of the brain to treat neuropsychiatric conditions such as Alzheimer's disease (
8), Tourette's syndrome (
9), obsessive-compulsive disorder (
10), and advanced depression (
11). According to recent studies on animals and humans, DBS may serve as an effective treatment for addiction. Investigating the effects of DBS on the responses to alcohol, cocaine, heroin, morphine, and nicotine has produced encouraging results in several areas of the reward system (
5). The effects of DBS are much more complex than simple local stimulation or inhibition. Instead, DBS has been shown to stimulate axonal terminals, exerting significant effects on neural circuits. However, the precise mechanism of DBS action has remained unknown. The impact of DBS depends on several parameters, such as the stimulated structure, its specific afferents and efferents, cell type, the ratio of primary neurons to interstitial neurons, mediating systems, etc. (
12). In addition, different brain structures have different conductivities, and this parameter can fluctuate as a result of neurophysiological changes in different neurological disease states for which DBS is already used (
13). However, DBS is a costly treatment for addicted patients that restricts access to available therapies (
14). The side effects of DBS depend on the targeted locations and its application, and include speech disorder, memory disorder, aggression, mild mania, sexual hyperactivity, depression, and increased risk of suicide; furthermore, it can change the main aspects of the patient's personality and behavior (
15). Insertion of stimulating electrodes can also lead to severe infections (
14).